Triple-negative breast cancer trials in Australia

In Australia 31 Also abroad 423

31 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in Australia
Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
Where
Adelaide, Box Hill, Camperdown, Clayton, Hobart, Melbourne, Nedlands, Sydney
Age
18 years to 42 years
People
75
Run by
Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT07527819
Phase 1/2Taking people
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
Where
Birtinya, Darlinghurst, Tugun
Age
18 years and over
People
100 worldwide
Run by
Gilead Sciences
See details and how to joinNCT06926920
Phase 1Taking people
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Where
Bedford Park, Buderim, Darlinghurst, Southport, Subiaco, Wollongong, Woolloongabba
Age
18 years and over
People
168 worldwide
Run by
OncoNano Medicine, Inc.
See details and how to joinNCT06022029
Phase 1/2Taking people
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Where
Wollstonecraft
Age
18 years and over
People
108 worldwide
Run by
Strand Therapeutics Inc.
See details and how to joinNCT06249048
Phase 1/2Taking people
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
Where
Darlinghurst
Age
18 years and over
People
65
Run by
St Vincent's Hospital, Sydney
See details and how to joinNCT04947189
Phase 1Taking people
Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
Where
Bedford Park, Darlinghurst, Malvern, Nedlands, Randwick, Westmead
Age
18 years and over
People
48
Run by
Myeloid Therapeutics
See details and how to joinNCT05969041